IL-12 activates STAT4, which is a critical regulator of inflammation and Th1 lineage development in murine systems. The requirement for STAT4 in the generation of human Th1 cells has not been examined thoroughly. Compared to control Th1 cultures, expression of the Th1 genes IFNγ, IL-12Rβ2 and TNFα is greatly reduced in Th1 cultures of CD4 T cells isolated from lymphoma patients following autologous stem cell transplant that have acquired STAT4 deficiency. Moreover, IL-4 and IL-5 production is increased in patient Th1 cultures though there are no defects in the development of Th2 cells. Reconstitution of STAT4 in patient T cells allowed recovery of IFNγ and IL-12Rβ2 expression, while ectopic expression of IL-12Rβ2 did not rescue STAT4 expression, and increased IFNγ production only to levels intermediate between control and patient samples. These results demonstrate that as in murine systems, STAT4 is required for optimal human Th1 lineage development.
Introduction
Following cytokine exposure, CD4+ T lymphocytes differentiate into distinct subsets of T helper (Th) cells, which regulate the immune response in resistance to pathogens. IL-12 promotes the differentiation of T helper type I (Th1) cells that produce the proinflammatory cytokine IFNγ, whereas IL-4 promotes the development of Th2 cells that secrete IL-4, IL-5 and IL-13. Signal Transducer and Activator of Transcription 4 (STAT4) is activated upon IL-12 binding to the receptor chains IL-12Rβ1 and IL-12Rβ2 1, 2 , and subsequently translocates to the nucleus where it binds target genes to activate transcription 3 . The requirement for IL-12 receptors in the development of Th1 immunity is demonstrated in human patients genetically deficient for IL-12Rβ1 4 .
Experiments with STAT4-deficient mice have demonstrated the requirement for STAT4 in IL-12 mediated biological functions including Th1 development and IFNγ production 5, 6 . However, the role of STAT4 in human Th1 differentiation has not been directly demonstrated.
We have previously described a profound deficiency in STAT4 expression by peripheral blood mononuclear cells (PBMCs) obtained from lymphoma patients after chemotherapy and autologous stem cell transplantation 7 . Post-transplant STAT4 deficiency is associated with markedly defective production of IFNγ in response to IL-12 both in vitro and in vivo 7, 8 . In this report, we have used STAT4-deficient post-transplant patient lymphocytes to define the role of STAT4 in the development of human Th1 cells.
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Materials and Methods

Human PBMC samples
PBMCs were obtained as previously described from patients with relapsed or refractory lymphoma who had undergone high-dose chemotherapy or chemoradiotherapy followed by autologous peripheral blood stem cell transplantation 7 . Control PBMCs were obtained from healthy volunteer donors. Patient blood samples were collected on a study approved by the Institutional Review Board at Indiana University Medical Center and written informed consent was obtained from each study subject in accordance with the Declaration of Helsinki.
T helper cell differentiation
CD4 + T cells isolation and differentiation are described in figure legends. Because patient samples used in this study were still CD4 T lymphopenic, it was required to pool isolated CD4 T cells from 2 to 5 patients to obtain sufficient number of cells for in vitro differentiation. Immunoblot was used to confirm STAT4-deficiency in cultured Th1 cells.
Quantitative PCR, Western blot, and flow cytometry were performed as described 7,9 . Cytokine was measured by ELISA or Luminex. For personal use only. on November 12, 2017. by guest www.bloodjournal.org From
Reconstitution of human STAT4 and IL-12Rβ2 expression
Results and Discussion
While mice are widely used models of the immune system, there are significant differences between murine and human immune systems [13] [14] [15] . Thus while STAT4 is an important component of Th1 differentiation in the murine system, the requirement for 16 . An impaired Th1 phenotype in patient samples was evident from reduced IFNγ production, compared to Th1 cells differentiated from normal subjects (Fig. 1C ). IL-12Rβ2, selectively expressed on human Th1 but not Th2 clones 17 , was reduced in STAT4-deficient human Th1 cultures ( Fig. 1D ), similar to other reports where STAT4 expression was diminished using siRNA oligonucleotides 18 . STAT4 deficiency was apparent in cultures even after three weeks of differentiation (data not shown) and was associated with significantly decreased IFNγ and TNFα 19 production, and increased IL-4 and IL-5 production in patient Th1 cultures, compared to control cells (Fig. 1E ). In contrast, long-term Th2 development was not impaired, and patient cultures had increased IL-4 production ( Fig. 1E ). These results suggest an important role for STAT4 in human Th1 differentiation and that human STAT4 may negatively regulate Th2 cytokines, as was observed in murine cells 5 .
Since post-transplant patient PBMCs could be deficient in other proteins in addition to STAT4, we next tested the ability of ectopic STAT4 expression to recover the Th1 phenotype in these cultures using two methods. Using transient transfection, patient For personal use only. on November 12, 2017. by guest www.bloodjournal.org From Th1 cells were successfully reconstituted with STAT4 expression ( Fig. 2A ) and
subsequently demonstrated significantly increased IFNγ production (Fig. 2C) . In contrast, ectopic expression of IL-12Rβ2 in patient Th1 cells, did not rescue STAT4 expression ( Fig. 2B) , though it did increase IFNγ production to levels intermediate between control and patient samples (Fig. 2C) . This result suggests that STAT4 has a dominant role in human Th1 development and IFNγ production. Since STAT4 levels are not completely absent in post-transplant patient lymphocytes, the partial recovery of IFNγ production in cells transduced with IL-12Rβ2 is likely due to the enhanced IL-12 signaling. IL-12Rβ2 expression enhanced IL-12 induced IFNγ production in wild-type but not STAT4-deficient cells, supporting the requirement for STAT4 in this response 20 .
Long term reconstitution of STAT4 in patient Th1 cells was achieved using a bicistronic retroviral vector encoded STAT4 and EGFP or EGFP alone 12 . Patient Th1 cells transduced with STAT4 retroviruses exhibited IFNγ (Fig. 2D, 2E ) and IL-12Rβ2 (data not shown) expression levels similar to those of vector-transduced control Th1 cells.
Thus, rescuing STAT4 expression restores Th1 differentiation in patient samples.
These results demonstrate that a deficiency of STAT4 in CD4 T cells isolated from posttransplant patient PBMCs results in defective Th1 development and validates a large body of work examining STAT4 function in the murine system 21 . These data further suggest that following certain chemotherapy regimens, a deficiency in STAT4 may impact attempts at immunotherapy that rely upon Th1 immunity and IFNγ production, or type I IFN signaling, which may also depend upon STAT4 in some conditions 22 . In contrast to STAT4 deficiency, expression and activation of STAT1 (not shown), STAT3 7 or STAT6 7 are normal in post-transplant patient PBMCs, and expression of T-bet is comparable in patient and control Th1 cultures (Fig. 1B) . Thus, acquired, restricted deficiency of STAT4 is intriguing and therapeutic attempts to modify STAT4 gene expression in human disease are warranted. 
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